GENIPHYS - NEW
  • Home
  • Technology
  • About
  • Resources
  • Careers
  • Contact

Recent Publications

  • Shay, E.O., Morrison, R.A., Zhang, L., Kaefer, S.L., Wesson, T., Cox, A., Voytik-Harbin, S.L. and Halum, S. (2024), Scaffold-Forming Collagen and Motor-Endplate Expressing Muscle Cells for Porcine Laryngoplasty. The Laryngoscope. 
  • Morrison, R.A., Brookes, S. et al. Engineered Collagen Polymeric Materials Create Noninflammatory Regenerative Microenvironments that Avoid Classic Foreign Body Responses. Biomater Sci 2023 Mar 21
  • Puls, T.J., Fisher, C.S., Cox, A. et al. Regenerative tissue filler for breast conserving surgery and other soft tissue restoration and reconstruction needs. Sci Rep 11: 2711, 2021
  • Sohutskay, D., Buno, K., Tholpady, S., et al. Design and biofabrication of dermal regeneration scaffolds:  role of oligomeric collagen fibril density and architecture.  Regen Med 15: 1295-1312, 2020
  • Stephens, C.H., Morrison, R.A., McLaughlin, M., et al. Oligomeric collagen as an encapsulation material for islet/β-cell replacement:  effect of islet source, dose, implant site and administration format. Am J Physiol Endocrinol Metab 319: E388-E400, 2020
  • Brooks, S., Zhang, L., Puls, T.J., et al. Laryngeal Reconstruction Using Tissue-Engineered Implants in Pigs:  A Pilot Study. Laryngoscope, 00:1-8, 2020
    ​

News


  • GeniPhys lands FDA clearance for wound care product (July 9, 2025)
  • Collymer SAS receives FDA 510(k) Clearance (July 8, 2025)
  • GeniPhys builds momentum with wound care technology (November 29, 2024)
  • Medtech Innovator GeniPhys Secures New Patent for Novel Collagen Biomaterial (October 30, 2024)​
  • GeniPhys receives SBIR Phase IIB Grant (October 22, 2024)
  • GeniPhys Secures $6 Million in Series A Funding (March 29, 2023)
  • Life sciences company GeniPhys Inc. receives $974,349 NSF SBIR Phase II grant (February 22, 2022)
  • Life sciences company GeniPhys adds president and CEO, and board chair (May 4, 2021)
  • ​Inside INdiana Business:  GeniPhys Develops First Breast Rebuilding Material (March 31, 2021)
  • Tissue filler, scaffold technologies provide new options for patients with breast cancer, other diseases (March 2, 2021)
  • Tissue-engineered implants provide new hope for vocal injuries (February 23, 2021)
  • New Type 1 diabetes therapy shows promise for long term reversal in both humans, dogs ( August 21, 2018)

​
Collymer SAS has only been cleared for specific uses by the FDA and is not yet commercially available.
Proudly powered by Weebly
  • Home
  • Technology
  • About
  • Resources
  • Careers
  • Contact